Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast-Reference-Cited by-同舟云学术

Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast

Published:2007-11-01 Issue:11 Volume:12 Page:1276-1287
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Boughey Judy C.¹,Gonzalez Ricardo J.²,Bonner Everett³,Kuerer Henry M.²

Affiliation:

1. a Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA

2. b Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas,USA

3. c Department of Surgery, Memorial Health University Medical Center, Savannah, Georgia, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Discuss the role of radiation therapy in the adjuvant treatment of DCIS.Describe the impact of tamoxifen in the treatment of DCIS.Discuss evolving strategies in neoadjuvant treatment for DCIS. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-11-1276

Reference69 articles.

1. Cancer statistics, 2005;Jemal;CA Cancer J Clin,2005

2. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: A dilemma;Ernster,1997

3. Breast carcinoma in situ: Risk factors and screening patterns;Claus;J Natl Cancer Inst,2001

4. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: Improved accuracy with directional, vacuum-assisted biopsy;Burbank;Radiology,1997

5. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: Results of surgical excision;Darling;AJR Am J Roentgenol,2000

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives;Japanese Journal of Clinical Oncology;2024-09-02

2. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study;Anti-Cancer Drugs;2022-06-20

3. Establishment of a new canine inflammatory mammary carcinoma cell line and analysis of its cystine-glutamate transporter subunit expression;Journal of Veterinary Research;2022-05-31

4. Exploring Ductal Carcinoma In-Situ to Invasive Ductal Carcinoma Transitions Using Energy Minimization Principles;Computational Science – ICCS 2022;2022

5. Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawaiʻi;JAMA Network Open;2021-10-20